Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease
Nutrients · 27.12.2024 · 17 (1) · 52
DOI: 10.3390/nu17010052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 27.12.2024. Verfasst von Anallely López-Yerena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut Recerca Sant Pau, Sant Quinti 77-79, 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Probiotics, Cardiovascular Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundacio la Marato, Spanish Ministry of Economy and Competitiveness of Science and Agencia Estatal de Investigación, MCIN.
Abstract (Originalsprache)
Probiotics are gaining recognition as a viable strategy for mitigating cardiovascular risk factors. Specifically, recent studies highlight their potential benefits in managing cholesterol levels, blood pressure, and inflammation, which are critical components in the prevention of cardiovascular diseases (CVD). This comprehensive review aims to elucidate the impact of probiotic consumption on major cardiovascular risk factors, including individuals with hypertension, type II diabetes mellitus, metabolic syndrome, hypercholesterolemia, and in secondary prevention in coronary artery disease. Scientific evidence based on human studies suggests that probiotic consumption is associated with positive effects on anthropometric measures, inflammation markers, blood pressure, glucose metabolism markers, lipid profiles, and endothelial function. However, these findings should be interpreted pragmatically and acknowledge the significant variability in results. This variability may be attributed to factors such as probiotic composition (single strain or multiple strains), the characteristics of the delivery matrix (food, capsules, and sachets), the duration of the intervention, the dosage regimen, and baseline health profiles of the participants. Incorporating probiotics as part of a comprehensive and healthy lifestyle approach can be considered a feasible strategy for both the prevention and management of CVD. However, further research is needed on factors influencing the effect of probiotics, such as: (i) optimal probiotic strain(s), (ii) appropriate dosage, (iii) duration of treatment, (iv) optimal delivery vehicle, and (v) sex-specific differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut Recerca Sant Pau, Sant Quinti 77-79, 08041 Barcelona, Spain.
- School of Pharmacy and Food Sciences, University of Barcelona (UB), 08036 Barcelona, Spain.
- Centro de Investigación Biomédica en Red Cardiovascular (CIBER-CV), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Cardiovascular Research Foundation for Health Prevention and Innovation (FICSI), 08017 Barcelona, Spain.
ORCID-Profile: Anallely López-Yerena, Teresa Padro
Förderung
- Fundacio la Marato
- Spanish Ministry of Economy and Competitiveness of Science and Agencia Estatal de Investigación
- MCIN
- Juan de la Cierva-Formación
Zitieren
APA
López-Yerena, A., de Santisteban Villaplana, V., Badimon, L., Vilahur, G., & Padro, T. (2024). Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease. Nutrients, 17(1), 52. https://doi.org/10.3390/nu17010052
Vancouver
López-Yerena A, de Santisteban Villaplana V, Badimon L, Vilahur G, Padro T. Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease. Nutrients. 2024;17(1):52. doi:10.3390/nu17010052
BibTeX
@article{LpezYerena2024,
author = {López-Yerena, Anallely and de Santisteban Villaplana, Victoria and Badimon, Lina and Vilahur, Gemma and Padro, Teresa},
title = {Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease},
journal = {Nutrients},
year = {2024},
volume = {17},
number = {1},
pages = {52},
doi = {10.3390/nu17010052}
}
EUVIMED